急性脊髄損傷市場レポート：2030年までの動向、予測、競合分析

急性脊髄損傷の動向と予測

世界の急性脊髄損傷市場は、2024年から2030年までのCAGRが5.6％で、2030年までに推定96億米ドルに達すると予想されます。この市場の主な促進要因は、早期治療の利点に対する意識の高まり、急性脊髄損傷の罹患率の上昇、エクストリームスポーツ活動の世界の人気の高まりです。世界の急性脊髄損傷市場の将来は、病院および外傷センター市場における機会によって有望視されています。

急性脊髄損傷市場の洞察

Lucintelは、脊髄損傷の罹患率の増加と脊髄損傷の治療に対する意識の高まりから、予測期間中、不完全脊髄損傷（ISCI）がより大きなセグメントであり続けると予測しています。

この市場では、病院での入院リハビリテーションプログラムが増加し、人々を支援する包括的なサービスが提供されるため、病院が引き続き大きなセグメントを占めると予想されます。

北米は、高齢化人口の急増、整備されたヘルスケアシステム、先進技術の採用増加により、引き続き最大の地域となる見込みです。

市場規模・推計：急性脊髄損傷の市場規模を金額（億米ドル）で推計。

動向と予測分析：各種セグメント別、地域別の市場動向（2018年～2023年）と予測（2024年～2030年）。

セグメント別分析：急性脊髄損傷市場規模をタイプ別、エンドユース別、地域別に金額（$B）で推計。

地域別分析：急性脊髄損傷市場の北米、欧州、アジア太平洋地域、その他世界のその他の地域内訳。

成長機会：急性脊髄損傷市場のタイプ別、最終用途別、地域別の成長機会分析。

戦略的分析：急性脊髄損傷市場のM&A、新製品開発、競合情勢など。

ポーターのファイブフォースモデルに基づく業界の競合強度分析。

本レポートは以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の急性脊髄損傷市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
• 世界の急性脊髄損傷市場動向（2018年～2023年）と予測（2024年～2030年）
• タイプ別の世界の急性脊髄損傷市場
  • 完全脊髄損傷
  • 不完全脊髄損傷
• 最終用途別の世界の急性脊髄損傷市場
  • 病院
  • トラウマセンター

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の急性脊髄損傷市場
• 北米の急性脊髄損傷市場
• 欧州の急性脊髄損傷市場
• アジア太平洋の急性脊髄損傷市場
• その他の地域の急性脊髄損傷市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • タイプ別の世界の急性脊髄損傷市場の成長機会
  • 最終用途別の世界の急性脊髄損傷市場の成長機会
  • 地域別の世界の急性脊髄損傷市場の成長機会
• 世界の急性脊髄損傷市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の急性脊髄損傷市場の能力拡大
  • 世界の急性脊髄損傷市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Novartis
• Tenax Therapeutics
• Accure Pharma
• Acorda Therapeutics
• Asterias Biotherapeutics
• ReNetX Bio
• BioArctic
• BioTime
• InVivo Therapeutics
• Kringle Pharma

Acute Spinal Cord Injury Trends and Forecast

The future of the global acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets. The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

A more than 150-page report is developed to help in your business decisions.

Acute Spinal Cord Injury by Segment

The study includes a forecast for the global acute spinal cord injury by type, end use, and region.

Acute Spinal Cord Injury Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Complete Spinal Cord Injury
• Incomplete Spinal Cord Injury

Acute Spinal Cord Injury Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Trauma Centers

Acute Spinal Cord Injury Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Acute Spinal Cord Injury Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acute spinal cord injury companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acute spinal cord injury companies profiled in this report include-

• Novartis
• Tenax Therapeutics
• Accure Pharma
• Acorda Therapeutics
• Asterias Biotherapeutics
• Renetx Bio
• Bioarctic
• Biotime
• Invivo Therapeutics
• Kringle Pharma

Acute Spinal Cord Injury Market Insights

Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Within this market, hospital is expected to remain the larger segment due to growing number of inpatient rehabilitation programs at hospitals to deliver comprehensive services to help people.

North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Features of the Global Acute Spinal Cord Injury Market

Market Size Estimates: Acute spinal cord injury market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acute spinal cord injury market size by type, end use, and region in terms of value ($B).

Regional Analysis: Acute spinal cord injury market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the acute spinal cord injury market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acute spinal cord injury market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the acute spinal cord injury market size?

Answer: The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030.

Q.2 What is the growth forecast for acute spinal cord injury market?

Answer: The global acute spinal cord injury market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the acute spinal cord injury market?

Answer: The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

Q4. What are the major segments for acute spinal cord injury market?

Answer: The future of the acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets.

Q5. Who are the key acute spinal cord injury market companies?

Answer: Some of the key acute spinal cord injury companies are as follows:

• Novartis
• Tenax Therapeutics
• Accure Pharma
• Acorda Therapeutics
• Asterias Biotherapeutics
• Renetx Bio
• Bioarctic
• Biotime
• Invivo Therapeutics
• Kringle Pharma

Q6. Which acute spinal cord injury market segment will be the largest in future?

Answer: Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Q7. In acute spinal cord injury market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the acute spinal cord injury market by type (complete spinal cord injury and incomplete spinal cord injury), end use (hospitals and trauma centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acute Spinal Cord Injury Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Acute Spinal Cord Injury Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Acute Spinal Cord Injury Market by Type
  • 3.3.1: Complete Spinal Cord Injury
  • 3.3.2: Incomplete Spinal Cord Injury
• 3.4: Global Acute Spinal Cord Injury Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Trauma Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Acute Spinal Cord Injury Market by Region
• 4.2: North American Acute Spinal Cord Injury Market
  • 4.2.2: North American Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
• 4.3: European Acute Spinal Cord Injury Market
  • 4.3.1: European Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
  • 4.3.2: European Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
• 4.4: APAC Acute Spinal Cord Injury Market
  • 4.4.1: APAC Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
  • 4.4.2: APAC Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
• 4.5: ROW Acute Spinal Cord Injury Market
  • 4.5.1: ROW Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
  • 4.5.2: ROW Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Type
  • 6.1.2: Growth Opportunities for the Global Acute Spinal Cord Injury Market by End Use
  • 6.1.3: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Region
• 6.2: Emerging Trends in the Global Acute Spinal Cord Injury Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Acute Spinal Cord Injury Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acute Spinal Cord Injury Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Novartis
• 7.2: Tenax Therapeutics
• 7.3: Accure Pharma
• 7.4: Acorda Therapeutics
• 7.5: Asterias Biotherapeutics
• 7.6: ReNetX Bio
• 7.7: BioArctic
• 7.8: BioTime
• 7.9: InVivo Therapeutics
• 7.10: Kringle Pharma